Trial Profile
PREVENTION OF LOW CARDIAC OUTPUT SINDROME IN NEWBORNS UNDERGOING CARDIAC SURGERY: A PILOT STUDY ABOUT DOSE-DEPENDENT PHARMACOKINETICS AND PHARMACODYNAMICS OF 2 INODILATORS
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2012
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary) ; Milrinone (Primary)
- Indications Heart failure; Low cardiac output
- Focus Pharmacodynamics; Pharmacokinetics
- 07 Nov 2012 Planned End Date changed to 12 Jun 2010.
- 27 Jun 2011 New trial record